関連する実験動画
Updated: Jan 8, 2026

13:45
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
10.3K
メルケル細胞がんを駆動する宿主とウイルスのシス調節ネットワークの連鎖
Lingling Miao1, David Milewski2, Amy Coxon1
1Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and.
The Journal of clinical investigation
|December 15, 2025
まとめ
メルケル細胞ポリオーマウイルスは、ヒト転写因子を乗っ取ることにより神経内分泌がんを駆動します。HDAC阻害剤でこれらのコア調節因子を標的とすると腫瘍の増殖が停止し、新しい治療戦略が提供されます。
科学分野:
- 腫瘍学
- ウイルス学
- エピジェネティクス
背景:
- ウイルスは、世界の癌の15%以上を引き起こす。
- メルケル細胞ポリオーマウイルス(MCPyV)は、メルケル細胞がんと関連するヒト腫瘍ウイルスである。
- MCPyVは、悪性ヒト腫瘍を引き起こすことが知られている唯一のポリオーマウイルスである。
研究 の 目的:
- MCPyVが神経内分泌がんを引き起こす分子メカニズムを調査する。
- 腫瘍生存に不可欠なウイルスおよび宿主因子を特定する。
- MCPyV駆動腫瘍を標的とする治療戦略を模索する。
主な方法:
- 転写因子結合部位を特定するためのクロマチン免疫沈降シーケンス(ChIP-seq)。
- MCPyV統合部位の分析。
- ヒストンデアセチラーゼ(HDAC)阻害剤を用いたinvitro研究。
主要な成果:
- MCPyV+メルケル細胞がんは、神経内分泌コア調節転写因子(ATOH1、INSM1、ISL1、LHX3、POU4F3、SOX2)を特徴とする。
- これらの因子は、腫瘍生存に不可欠なスーパーエンハンサーでウイルス小T抗原とともにクロマチンに結合した。
- MCPyVの統合部位は、神経内分泌スーパーエンハンサーで濃縮された。
- MCPyV非コード制御領域のユニークなホメオドメイン結合モチーフは、T抗原発現に不可欠なISL1とLHX3に結合した。
- HDAC阻害剤は、クロマチン構造を破壊し、コアTFの発現を枯渇させ、腫瘍の増殖を停止させた。
結論:
- MCPyVは、ウイルスおよび宿主のエピゲノム回路間に発がん性交差調節を確立する。
- これにより、MCPyVの神経内分泌がんにおける役割を説明する必須の転写フィードバックループが作成される。
- これらのコア調節因子を標的とすることは、MCPyV駆動がんの有望な治療アプローチを表す。
関連する概念動画
Mechanisms of Retrovirus-induced Cancers
6.8K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K

